‹ ›
MYP_003502
← PREVIOUS NEXT → BACK
Basic Information
P161(derived from HCV polyprotein)
Antimicrobial
Antiviral
Antiviral ▸ Anti-Hepatitis virus ▸ Anti-HCV
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Enzyme modulation ▸ Enzyme inhibition ▸ Protease inhibition
Standard
13 amino acids
C86H139N17O14
Standard
Sequence
KKKKLLLPFLFLF
Physicochemical Analysis
1635.13 Da
10.48
3.76
3.55
0.2889
0.78
0.33
0.23
32.33
150.00
0.2308
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
507.81
3.20
17.0
18.0
56.0
117.0
4.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0063613 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease
4 %
Inhibition
PaperPeptide inhibitors of hepatitis C virus NS3 protease. Antivir Chem Chemother. 2003 Sep;14(5):225-33. doi: 10.1177/095632020301400501. PMID: 14694985. PMID14694985 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14694985/
RECORD: Rec_0101563 VERIFIED: YES
Provenance & Taxonomy
Hepatitis C virus [Virus]
Virus-derived peptide
3052230;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Protease inhibitor
Hepatitis C virus (NS3 protease); BL21(DE3)
4 %
Fluorescent probe
PaperPeptide inhibitors of hepatitis C virus NS3 protease. | Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F. | Antivir Chem Chemother. 2003 | PMID:14694985 PMID14694985 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14694985/
RECORD: Rec_0283310 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0309464 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperPeptide inhibitors of hepatitis C virus NS3 protease. Antivir Chem Chemother. 2003 Sep;14(5):225-33. doi: 10.1177/095632020301400501. PMID: 14694985. PMID14694985 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14694985/
RECORD: Rec_0333548 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HCV Replication inhibition
Hepatitis C virus (HCV)
3 μM
% inhibition
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperPeptide inhibitors of hepatitis C virus NS3 protease. | Portal-Núñez S, González-Navarro CJ, García-Delgado M, Vizmanos JL, Lasarte JJ, Borrás-Cuesta F. | Antivir Chem Chemother. 2003 Sep;14(5):225-33. | DOI:10.1177/095632020301400501 | PMID:14694985 PMID14694985 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/14694985/